Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 47 | $18,210,349 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 May 2024 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Chief Scientific Officer | 15 May 2024 | Sale | 54 | 430.93 | 23,270 | D |
27 Feb 2024 16:24 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 26 Feb 2024 | Sale | 4,239 | 425.7 | 1,804,542 | D |
23 Feb 2024 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2024 | Sale | 3,002 | 421.77 | 1,266,154 | D |
21 Feb 2024 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 20 Feb 2024 | Sale | 4,002 | 420.79 | 1,684,002 | D |
13 Feb 2024 16:46 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 12 Feb 2024 | Sale | 3,145 | 420.24 | 1,321,655 | D |
17 Nov 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 15 Nov 2023 | Sale | 19 | 369.92 | 7,028 | D |
11 Aug 2023 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 09 Aug 2023 | Sale | 63 | 345.51 | 21,767 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 302 | 289.6 | 87,459 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 300 | 288.74 | 86,622 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 3,636 | 287.23 | 1,044,368 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 900 | 294.73 | 265,257 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 1,843 | 294.03 | 541,897 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 1,223 | 292.76 | 358,045 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 36 | 291.01 | 10,476 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 308 | 301.02 | 92,714 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 1,888 | 300.11 | 566,608 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 2,165 | 299.08 | 647,508 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 395 | 297.97 | 117,698 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 842 | 296.85 | 249,948 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 800 | 295.79 | 236,632 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 500 | 300.23 | 150,115 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 1,893 | 299.36 | 566,688 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 2,160 | 298.47 | 644,695 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 245 | 296.44 | 72,628 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 153 | 309.06 | 47,286 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 620 | 306.7 | 190,154 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 349 | 305.08 | 106,473 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 100 | 303.64 | 30,364 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 70 | 302 | 21,140 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 12 | 300.39 | 3,605 | D |
17 Nov 2022 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 15 Nov 2022 | Sale | 34 | 308.61 | 10,493 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 83 | 306.57 | 25,445 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 140 | 305.39 | 42,755 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 280 | 304.58 | 85,282 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 261 | 303.21 | 79,138 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 189 | 301.99 | 57,076 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 210 | 300.96 | 63,202 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 140 | 299.72 | 41,961 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 146 | 295.14 | 43,090 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 302 | 293.99 | 88,785 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 210 | 293.02 | 61,534 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 424 | 291.53 | 123,609 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 222 | 290.32 | 64,451 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 6,604 | 289.48 | 1,911,726 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 5,737 | 288.67 | 1,656,100 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 4,561 | 287.83 | 1,312,793 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 963 | 286.72 | 276,111 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)